Cargando…

Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancer

BACKGROUND: There is no standard procedure available to diagnose and treat with pregnancy-associated non-small cell lung cancer (NSCLC). The present study was to investigate the clinical and molecular features, and the proper intervention timing for this population. METHODS: This is a retrospective,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lei, He, Yun-Ting, Kang, Jin, Zheng, Ming-Ying, Chen, Zhi-Hong, Yan, Hong-Hong, Zhang, Xu-Chao, Yang, Jin-Ji, Wu, Yi-Long, Zhou, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339795/ https://www.ncbi.nlm.nih.gov/pubmed/34422342 http://dx.doi.org/10.21037/jtd-21-234

Ejemplares similares

Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer
por: Wei, Xue‐Wu, et al.
Publicado: (2020)

Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancer
por: Gao, Hong-Fei, et al.
Publicado: (2016)

Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer
por: Gao, Xin, et al.
Publicado: (2020)

Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status
por: An, She-Juan, et al.
Publicado: (2012)

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
por: Kang, Jin, et al.
Publicado: (2020)

Selective lymph node dissection for clinical T1 stage non-small cell lung cancer
por: Zhao, Jin-Long, et al.
Publicado: (2019)

BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification
por: Jiang, Ben-yuan, et al.
Publicado: (2013)

Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer
por: Kang, Jin, et al.
Publicado: (2018)

Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
por: Zhang, Shi-Ling, et al.
Publicado: (2023)

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression
por: Chen, Rui-Lian, et al.
Publicado: (2018)

Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients
por: Wang, Zhen, et al.
Publicado: (2023)

Artificial Intelligence Algorithm-Based Analysis of Ultrasonic Imaging Features for Diagnosis of Pregnancy Complicated with Brain Tumor
por: Wu, Lin, et al.
Publicado: (2021)

Clinical features and hypoxic marker expression of primary sinonasal and laryngeal small-cell neuroendocrine carcinoma: a small case series
por: Chai, Liang, et al.
Publicado: (2014)

The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer
por: Gou, Lan-Ying, et al.
Publicado: (2016)

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations
por: Lou, Na-Na, et al.
Publicado: (2016)

Clinical outcomes of EGFR +/ METamp+ vs. EGFR +/ METamp‐ untreated patients with advanced non‐small cell lung cancer
por: Peng, Kai‐Cheng, et al.
Publicado: (2022)

Distribution and prognosis of uncommon metastases from non-small cell lung cancer
por: Niu, Fei-Yu, et al.
Publicado: (2016)

Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer
por: Deng, Jia-Yi, et al.
Publicado: (2023)

Clinical features and outcome of acute hepatitis B in pregnancy
por: Han, Yong-Tao, et al.
Publicado: (2014)

Establishment of a Novel Method for Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance Mutations in Lung Cancer
por: Tian, Hong-Xia, et al.
Publicado: (2017)

Responses to: pregnancy-associated lung cancer: a clinical and scientific challenge more than treatment dilemma
por: He, Yun-Ting, et al.
Publicado: (2021)

Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer
por: Yang, Xiao-Rong, et al.
Publicado: (2020)

MicroRNA-34c-3p target inhibiting NOTCH1 suppresses chemosensitivity and metastasis of non-small cell lung cancer
por: Yang, Lin-zhu, et al.
Publicado: (2020)

Continuous intravenous infusion of recombinant human endostatin using infusion pump plus chemotherapy in non-small cell lung cancer
por: Qin, Zhi-Quan, et al.
Publicado: (2022)

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis
por: Zheng, Mao-hua, et al.
Publicado: (2016)

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients
por: Tian, Hong‐xia, et al.
Publicado: (2022)

The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells
por: Kang, Dong Young, et al.
Publicado: (2020)

Prognostic value of adjuvant therapy in T4 non‐small cell lung cancer: An inverse probability of treatment weighting analysis
por: Song, Ya‐ting, et al.
Publicado: (2019)

Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines
por: Bai, Xiao-Yan, et al.
Publicado: (2016)

Evaluation of ALK Rearrangement in Chinese Non-Small Cell Lung Cancer Using FISH, Immunohistochemistry, and Real-Time Quantitative RT- PCR on Paraffin-Embedded Tissues
por: Zhang, Yun-Gang, et al.
Publicado: (2013)

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial
por: Zhou, Qing, et al.
Publicado: (2016)

Antitumor effect of kurarinone and underlying mechanism in small cell lung carcinoma cells
por: Chung, Ting-Wen, et al.
Publicado: (2019)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

Heterogeneity of the resistance to gefitinib treatment in a non‐small cell lung cancer patient with active epidermal growth factor receptor mutation
por: Xu, Chong‐Rui, et al.
Publicado: (2016)

High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes
por: Liu, Kun, et al.
Publicado: (2016)

Bowel Perforation after Erlotinib Treatment in a Patient with Non-Small Cell Lung Cancer
por: Cheon, Yun-Hong, et al.
Publicado: (2011)

Bilateral lung transplantation after caesarean section in pregnancy with severe pulmonary arterial hypertension: A case report
por: Ye, Jia, et al.
Publicado: (2019)

Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non–Small Cell Lung Cancer
por: Zhang, Jia-Tao, et al.
Publicado: (2022)

Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay
por: Su, Jian, et al.
Publicado: (2014)

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
por: Shen, Hong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n9g1uqp2p5bqnr3d6le1e5b5qu